We discuss the longevity of the Mabry syndrome index patients in the context of the utility of pyridoxine treatment of seizures and evidence for putative glycolipid storage in patients with HPMRS3. The gene discussed is PGAP2; the disease is hyperphosphatasia-intellectual disability syndrome.